New insider activity at Eli Lilly & Co ( (LLY) ) has taken place on November 4, 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Significant shareholder Lilly Endowment Inc has sold 300,000 shares of Eli Lilly & Co stock, amounting to a transaction worth $266,647,679.
Spark’s Take on LLY Stock
According to Spark, TipRanks’ AI Analyst, LLY is a Outperform.
Eli Lilly & Co’s strong revenue growth and market share gains, highlighted in the earnings call, are significant positives. The technical indicators also suggest bullish momentum. However, high valuation and leverage, along with declining cash flow metrics, present potential risks. Overall, the stock is well-positioned but requires careful monitoring of financial leverage and cash flow management.
To see Spark’s full report on LLY stock, click here.
More about Eli Lilly & Co
YTD Price Performance: 16.83%
Average Trading Volume: 4,519,757
Technical Sentiment Signal: Strong Buy
Current Market Cap: $847.6B